Cancer genes disfavoring T cell immunity identified via integrated systems approach
Rigel J. Kishton, Nicholas P. Restifo(Lyell Immunopharma (United States)), Tori N. Yamamoto(National Cancer Institute), Devikala Gurusamy(National Institutes of Health), Amanda N. Henning(National Cancer Institute), Neville E. Sanjana(New York Genome Center), Maggie Cam(Office of Science), Yogin Patel(National Cancer Institute), Suman K. Vodnala(National Cancer Institute), Zhiya Yu(Mayo Clinic in Arizona), Kris C. Wood(Duke University), Anna Pasetto(National Cancer Institute), Douglas C. Palmer(AstraZeneca (Japan)), Roxana A. Stefanescu, Winifred Lo(National Cancer Institute), Andrew T. Girvin, Madhusudhanan Sukumar(Johnson & Johnson (United States)), Michelle Ji(National Cancer Institute), Drew C. Deniger(The University of Texas MD Anderson Cancer Center), Shashank J. Patel(National Institutes of Health), Amy E. Decker(Duke University), Parisa Malekzadeh(City of Hope)
Cited by 15
Related Papers
Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function
|Journal of Clinical Investigation|2013|930
Identification of essential genes for cancer immunotherapy
|Nature|2017|890
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation
|Journal of Clinical Investigation|2014|717
CRMP-5 neuronal autoantibody: Marker of lung cancer and thymoma-related autoimmunity
|Annals of Neurology|2001|569